Calliditas: Another orphan drug designation granted by the FDA
Research Note
2019-02-12
12:54
Earlier today, Calliditas announced that the FDA has granted orphan drug designation for the treatment of primary biliary cholangitis (PBC).
MS
Mathias Spinnars
Disclosures and disclaimers